We examine the expression pattern of ZnT3 in the cerebral and cerebellar areas of mouse brain throughout development. During embryogenesis and early postnatal stages, ZnT3 transcripts were detected in several areas. Label was clear in areas related to proliferation and differentiation. As development proceeded, the label gradually disappeared in these areas and increased in the chelatable vesicular zinc (CVZ) system. To assess whether ZnT3 was expressed in all CVZ cells, its distribution pattern was studied through postnatal stages using a retrograde zinc transport method. While the ZnT3 expression pattern and the distribution of CVZ cells coincided from P12 to adulthood, this coincidence was not detected in early postnatal days. Moreover, immunohistochemical procedures highlighted a differential phenotype within CVZ cells throughout postnatal development. These findings suggest the presence of different CVZ cell subpopulations throughout brain development and, consequently, the existence of distinct chelatable vesicular zinc pools.
INTRODUCTION
Zinc is an essential component of a wide variety of proteins. It is part of the active site of metalloenzymes and stabilizes protein domains of several motifs commonly found in transcription factors (Vallee and Falchuck, 1993; Rhodes and Klug, 1993) . In addition, the mammalian brain contains an important chelatable vesicular zinc (CVZ) pool (5-10 % of total zinc). It is mainly located in synaptic vesicles of a subset of glutamatergic neurons, called chelatable vesicular zinc neurons (Haug 1967; Pérez-Clausell and Danscher, 1985; Beaulieu et al., 1992) . This vesicular zinc may contribute to synaptic neurotransmission and endogenous neuromodulation of several important receptors. These receptors include ␥-aminobutyric acid (GABA), N-methyl-d-aspartate (NMDA) receptors, and ␣-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)/ kainate receptors (Harrison and Gibbons, 1994; Smart et al., 1994; Huang, 1997) .
These essential zinc roles implicate an adequate zinc homeostasis to support different biological functions. The zinc cation is a small hydrophilic ion. It does not cross biological membranes by passive diffusion (da Silva and Williams, 1991) . Therefore, cells need to adjust the rate of zinc influx and efflux, binding to intracellular and extracellular proteins (or other molecules) and sequestrating into vesicles and organelles (Reyes, 1996) . Methallothionein proteins (MTs) have been implicated in such homeostatic control and in the regulation of the intracellular levels of free zinc through intracellular binding (Erickson et al., 1997; Davis and Cousins, 2000) . They control the transfer of zinc to cytoplasmatic and nuclear proteins (Jacob et al., 1998; Beyersmann and Haase, 2001 ), especially to transcription factors with a zinc finger domain (Maret et al., 1999) . Some of the MTs (e.g., MT-III and MT-IV) are abundant in the brain (Palmiter et al., 1992; Pountney et al., 1994) . But MTs never provide long-term storage for zinc because they have a short biological half-life in cells (Krezoski et al., 1988) . Hence, the control of cellular zinc homeostasis can only be explained by the existence of several proteins or proteins complexes associated with zinc transport.
In eukaryotes, two families of zinc transport have been identified, the ZIP and the CDF families (Gaither and Eide, 2001 ). The Zrt-, Irt-like proteins (ZIP transporters) are named after two of the first members of the family to be identified, Zrt1 of Saccharemyces cerevisiae and Irt1 of Arabidopsis thaliana Zhao and Eide, 1996) . In addition, in S. cerevisiae, members of the CDF family such as Zrc1, Cot1, and Msc2 have been identified. In mammals, zinc transporters of both the ZIP and the CDF families have also been found. To date, 12 ZIP genes have been identified in humans (e.g., hZip1 and hZip2) and 3 in mice. Concretely, hZip1 and hZip2 appear to play roles in zinc uptake across the plasma membrane Eide, 2000, 2001) . McMahon and Cousins (1998) have extensively reviewed the isolation and characterization of CDF family zinc protein transporters. Thus, four putative mammalian zinc transporters have been cloned: ZnT1 (Palmiter and Findley, 1995; McMahon and Cousins, 1998) , ZnT2 (Palmiter et al., 1996a) , ZnT3 (Palmiter et al., 1996b) , and ZnT4 (Huang and Gitschier, 1997) . All of these proteins, with multiple membrane-spanning regions, exhibit characteristics of the zinc transporter family, such as a histidine-rich region (loop) oriented on the cytosolic side. ZnT1, which resides in the plasma membrane, exports zinc from the cell and appears to be expressed ubiquitously (Palmiter and Findley, 1995) . ZnT2 is localized to acidic vesicles. It is mainly found in the small intestine, the kidneys, the testis, and the seminal vesicles (Palmiter and Findley, 1996a) . ZnT3 is restricted to the brain and testis. In particular, it has been found in the membrane of the synaptic vesicles in the brain, where it is involved in zinc uptake (Palmiter et al., 1996b) . ZnT4 is also widely present and is localized to the endosomal vesicles, (Murgia et al., 1999) . ZnT4 has been implicated in zinc sequestration inside an intracellular compartment and in the deposition of zinc in maternal milk (Huang and Gitschier, 1997) . Moreover, the high expression of ZnT4 in the brain suggests a more extensive role in zinc metabolism. The regulation of the number, activity, and cellular location of all these transporters may be important in zinc homeostasis. Hence, special attention should be paid to the genes encoding these transporters.
In mammals, another type of metal divalent cation transporter, DCT1, with a high affinity for both zinc and iron, has been cloned from rat intestine (Gunshin et al., 1997) . It is also called Nramp2 (Fleming et al., 1998) since it is a member of the Nramp family that is unrelated to either ZIP or CDF proteins.
At present, ZnT3 is the most commonly studied zinc transporter in the central nervous system (CNS). In the adult, ZnT3 expression and ZnT3 protein distribution were high in the cortical layers, in granular and pyramidal cells (CA1 and CA3 regions) of the hippocampal formation, and in their projections (Palmiter et al., 1996b; Wenzel et al., 1997) . The Danscher method, a histochemical method that detects zinc in synaptic vesicles, and ZnT3 immunohistochemistry give a similar staining pattern in adult rat brain (Frederickson and Danscher, 1992; Slomianka, 1992; Pérez-Clausell, 1996; Palmiter et al., 1996b) , suggesting that ZnT3 is involved in a package of zinc in these vesicles. This finding was supported by ultrastructural studies showing that ZnT3 was mainly located in the membrane of those zinc vesicles stained by the Danscher method. (Wenzel et al., 1997) . Cole et al. (1999 Cole et al. ( , 2000 have confirmed this hypothesis, reporting that targeted disruption of the ZnT3 gene reduced the levels of ZnT3 protein in membranes of zinc synaptic vesicles and reporting lower amounts of vesicular zinc. Moreover, a mutant mouse, mocha, lacking a protein (AP-3d) involved in vesicle cargo selection is unable to insert the ZnT3 protein into the vesicles. Like the ZnT3 knockouts, AP3-deficient mutants also fail to sequester zinc in vesicles (Kantheti et al., 1998) . Thus, expression of ZnT3 without the AP3 protein complex could easily explain the lack of functional zinc transport in places where ZnT3 mRNA is detected, indicating that a protein complex must be involved in vesicular zinc uptake.
In an earlier study on rat brain during development (Valente et al., 2002) , zinc-rich terminal fields were observed in the first postnatal days (mainly in septum, hippocampus, and amygdala). Hence, if ZnT3 is involved in zinc uptake into zinc synaptic vesicles, its expression would appear to be evidenced early in development, in coincidence with the pattern of CVZ neurons. The present paper seeks new insights into the function of ZnT3 in the central nervous system during development by studying the distribution pattern of ZnT3 mRNA in brain by a nonradioactive in situ hybridization method. In addition, in order to determine whether ZnT3 is expressed in all the CVZ neurons, we used the retrograde selenium method (Danscher, 1984) to analyze the distribution pattern of these cells during development. We also attempted to characterize their phenotype by the retrograde-immunohistochemistry method.
RESULTS

Embryonic Expression of ZnT3
On E16 -E18, the ZnT3 gene was clearly defined in cells of the ventricular zone, the subventricular zone, the cortical plate, and the piriform cortex (Figs. 1B, 1C , and 1E). In addition, intense expression was detected in the olfactory bulb (nerve layer, accessory, and neuroepithelium) (Fig. 1A) . On these days, ZnT3 was diffusely expressed in the other cerebral areas, whereas no label was detected in the posterior brain areas or the cerebellum (medullar nuclei) (Fig. 1D ).
Expression Pattern of ZnT3 during Postnatal Development
Anterior brain areas. On P0 -P5, high label intensities were detected in the nerve layer and in the accessory olfactory bulb ( Fig. 2A ). Weak expression of ZnT3 was observed in the septum, the striatum, the upper layers of the cingular cortex (Figs. 2C and 2D) , the subventricular zone, and the ependymal layer. At these stages, diffuse ZnT3 expression was also found in the corpus callosum and in the anterior commissure (Figs. 2C and 2D) . This expression was maintained until P9 and disappeared in the following days (Figs. 2E, 2H , and 6B).
On P7, the accessory olfactory bulb and nerve olfactory layer still showed strong label intensity. Moreover, at this time cells located in the mitral layer began to show label (Fig. 2B ). In the olfactory bulb neuroepithelium, ZnT3 mRNA transcripts were seen, as occurs during embryonic stages. In the upper layers of the cingular cortex, a compacted layer of labeled cells was visualized. On the other hand, on this postnatal day, a marked decrease in label was observed in areas such as thalamus, striatum, and septum.
On P9, within proliferative areas such as the subventricular zone and the ependymal layer, a decrement in labeling was observed (Fig. 2E ). This decline progressed during late postnatal days and continued into adulthood (Figs. 2F and 6B) . Nevertheless, strong signals of ZnT3 mRNAs were detected in the upper layers of the cingular cortex (Fig. 2E ). In the neocortical areas, no laminar pattern was visualized yet. However, in the anterior somatosensorial area, the barrel fields were clearly defined (see arrows in Fig. 2E ). Other areas such as the striatum and the septum were now devoid of label.
Medial and posterior brain areas. During the first postnatal days (P0 -P5), the ZnT3 gene was slightly expressed in the pyramidal cells of the hippocampus (Fig. 3A) , whereas the label in dentata gyrus started on P5-P7 (Fig. 3B ). On P7, the levels of ZnT3 transcripts increased in pyramidal cells of the hippocampus (Figs. 3B and 3C) . In the hilus, the cells became steadily more located in granular layers (supragranular) and the ZnT3 expression began to be perceived clearly (Figs. 3B and 3C). At the hippocampal level, on P9, no changes were detected.
In the entorhinal and piriform cortices and in the amygdaloid area the label was clearly observed on P0 -P1 (Fig. 4A) . On P7, an increase of label was detected in lower layers of the entorhinal and piriform cortices where the neurons were very compacted (Fig.  4B) .
On P9, strong signals of ZnT3 mRNAs were detected in the amygdala, especially in the lateral amygdaloid dorsolateral nucleus (LaDL) and basolateral amygdaOn P9, in proliferative areas such as the subventricular zone (svz), the hybridization signals increase. The label in the corpus callosum (cc) is still present while it drops in caudate putamen (CPu). In the neocortex, the ZnT3 mRNA levels clearly increase, mainly in the upper layers of the different cortical areas (M, motor; S, somatosensorial; and Cg, cingular) . Even though the laminar pattern is still not defined, in the somatosensorial area the barrel fields are well detected (arrows). This lends support to the label specificity obtained in zinc circuits. (F and G) Note that on P12 the label in svz is decreased. In the cingular cortex, layers II and III are less compacted than they were previously. A high magnification of this cortical area (G) reveals the laminar pattern already appearing and the presence of mRNA transcripts located in all of the neuronal soma. Magnification: 40ϫ (A), 36ϫ (B), 13.5ϫ (C), 11.5ϫ (D), 23.5ϫ (E), 26ϫ (F), and 55ϫ (G).
FIG. 2. Postnatal expression pattern of ZnT3 in the anterior brain areas. (A)
The micrograph shows how, on P1-P3, the label in the olfactory bulb neuroepithelium (obn) reveals a decrement compared with preceding embryonic stages (see micrograph 1A). Again, the olfactory accessory bulb (AOB) appears with a strong label. (B) From P5 to P9 a steady increase in the olfactory bulb neuroepithelium (obn) is detected, and at these stages hybridization signals of label appear in the mitral layer (Mi). The strong label in the olfactory accessory bulb (AOB) is maintained. (C and D) On P1-P3 the levels of ZnT3 mRNA transcripts decrease from previous stages. At this time, the label is clearly present in the corpus callosum (cc) and in the anterior commissure (ac). Note the increase of label in the cingular cortex (*). (E)
FIG. 3. Postnatal expression of ZnT3 in the hippocampal formation.
(A) On P1 practically no label is found in the hippocampal area (see the pyramidal cells (Py) and dentata gyrus (DG)). In this micrograph, the label within white matter (wm) is clearly observed and begins to be present in the retrosplenial cortex (RS). (B) On P7, the label in Py of CA1 to CA3 areas and in granular cells of the dentata gyrus (GrDG) has increased from preceding days. (C) High magnification of the dentata gyrus on P7. Note that the levels of label are higher in the upper layer of the GrDG than in the lower layer. (D) High magnification of the dentata gyrus on P12. Note that the label in GrDG increased in both layers from preceding days but decreased in the hilus (hi). Magnification: 19ϫ (A), 21ϫ (B), 46ϫ (C), and 35ϫ (D).
loid anterior nucleus (BLA) nuclei (Fig. 4C) . However, the expression was absent in the anterior cortical amygdaloid nuleus (ACo). In the lateral olfactory tract (LOT 3 and LOT 2), which connects with the olfactory nerve layer, slight label was seen (Fig. 4C ). In the thalamus, only the paraventricular and posterior medial nuclei were labeled and maintained until adulthood.
Cerebellar areas. From P0 to P3 a diffuse label was found in cerebellar areas, especially in external granular layer (EGL) and in different medullar nuclei (Figs. 5A and 5B). On P5, the expression of ZnT3 was detected in different cerebellar nuclei, such as posterior pons, trapezoid body, and superior peduncle and it was maintained in EGL. From P7, the expression decreased in EGL while the label increased at the internal granular layer (IGL) (Figs. 5H and 5I).
Expression Pattern of ZnT3 during Late Postnatal Stages to Adulthood
Olfactory brain areas. From P12 onward, the final expression pattern of ZnT3 was established. Thus, the label was maintained in the accessory olfactory bulb and in the olfactory nerve layer, but this label was less intense than in preceding days (Fig. 6A ). In addition, a moderate expression was observed in the lateral nucleus of the olfactory tract (LOT) (Fig. 6E ) and in the anterior olfactory lateral nucleus.
Neocortical brain areas.
At this period, a neocortical layer specification started, concretely on P12 (Figs. 2F and 2G). As occurred in previous stages, a high expression in the upper layers of the cingular and the retrosplenial cortices appeared (Figs. 2F, 6B, and 6D). In the anterior somatosensorial cortex, the label was detected in practically all the neurons located in layers II-III, whereas only a few neurons were identified in other layers (layer V) (Fig. 6B) . In posterior cortical areas, such as the motor, auditory, and visual areas, an increment of the label in layer V was seen (Fig. 6I) . Layer VI was always devoid of label.
Medial and posterior brain areas. In the hippocampus, differences in neuronal label intensity among pyramidal areas were established as development proceeded. Thus, the CA2 began devoid of label (Figs. 6D and 6I), whereas, in the dentata gyrus, the label increased (Figs. 3D, 6D, and 6I).
At this time the expression of ZnT3 appeared in some thalamic nuclei, such as paraventricular and intermediodorsal thalamic nuclei (Fig. 6D) . In addition, a steady increase in the intensity of label was determined in the piriform cortex (Figs. 6F and 6G) and in the amygdaloid nuclei (Fig. 6F) . From P12 and onward, the transcripts were located in the neuronal soma, as observed in Figs. 2F, 2G, and 6G.
In the adult cerebellum, the expression of ZnT3 disappeared in all the cerebellar layers (Fig. 6H) . However, the label was maintained in the cerebellar nuclei, i.e., the posterior pons, the trapezoid body, and the superior cerebellar peduncle (data not shown). 
FIG. 4.
Postnatal expression pattern of ZnT3 in the piriform cortex and in the amygdaloid area. (A and B) As these micrographs show, the intensity of label increases in the piriform cortex (pir) and in the amygdaloid area (aa) as development proceeds. (C) On P9, in the piriform (pir) and perirhinal cortices (PRh), a laminar pattern is visualized. In the amygdaloid area, an intense label is revealed in LaDL nucleus (arrows) while it appears slight in the BLA nucleus. Note that in the anterior cortical amygdaloid nucleus the label is totally absent (arrow box). This differential label within amygdaloid nuclei supports the specificity of the probe used. On P9, label appears for the first time in the lateral olfactory tract (LOT). Magnification: 15.8ϫ (A-C).
Pattern of CVZ Cells during Development
In order to analyze whether ZnT3-positive cells were CVZ cells, we determined their distribution by the retrograde selenium method throughout development.
On P1, moderate labeling was detected in different neuroepithelia such as the second ventricle (Figs. 7A and 7B), the third ventricle (Figs. 7C, 7D , and 7G), the aqueduct of Sylvius (Figs. 7H and 7G) , and the fimbria (Figs. 7C and 7E ). At this time label was also observed inside specific regions. Thus, a cellular subpopulation, located on the edge of the optic tract was detected (Fig.  7C) , however, these marked cells disappeared as development proceeded. In areas such as the choroid plexus and the dentata gyrus of the hippocampus, a moderate label was also observed (Fig. 7C) . Moreover, a strong cell label was detected in the arcuate nucleus of the hypothalamus (Fig. 7G ) and in the medial septum (Fig.  7A ). These findings supported the hypothesis of connections within the hypothalamus and the septum (Miller and Mogenson, 1972; Varoqueaux and Poulain, 1998) . In the cerebellum, moderately labeled cells were seen in the external granular layer (Fig. 7F) . At this time, the remaining cerebral and cerebellar areas were devoid of label.
On P5, a decrease in the cell intensity marker was detected within the septum (Fig. 8C ) and within the neuroepithelia of the second and third ventricles (Figs. 8A, 8B, and 8E). In contrast, labeled cells appeared for the first time in the piriform cortex (Fig. 8D) , in the accessory olfactory bulb, in the corpus callosum, and in the upper cortical layers. At the cerebellar level, intensely labeled cells were detected at the locus coerelus nucleus (Figs. 8F and 8G) . Moreover, some cells positioned in the neurepithelia of the fourth ventricle were strongly labeled (data not shown).
On P9, a slight cell label appeared for the first time in the different bulb olfactory areas, especially in granular layer and in the lateral olfactory bulb (mainly in LOT 3) (Fig. 9K) . However, at this time, the distribution pattern of labeled cells started to coincide with the cerebral zinc increase in the intensity of label is detected in the piriform cortex (pir). As is observed in F, the differential label within the amygdaloid nuclei is still detected with a high specificity. In the LaDL nucleus (arrow), the label is higher than in the BLA nucleus. At this time (E), the label is decreased in the lateral olfactory tract (LOT). (A) In adult, the levels of ZnT3 mRNAs in accessory olfactory bulb (AOB) and in the olfactory nerve bulb (on) are clearly defined. However, a decrement from preceding days is perceived, especially in the olfactory bulb neuroepithelium (obn) where the label almost disappears. (B) The label in upper layers, though weaker, is clearly defined, especially in the cingular and motor cortices. In the anterior somatosensorial cortex, the label was detected in practically all the neurons located in layers II-III, whereas only a few neurons in other layers (layer V) were identified. The label is disappearing in the subventricular zone (svz), in the caudatem putamen (Cpu), and in the corpus callosum (cc). (C) This micrograph shows the totally absence of the label when the ZnT3 sense probe is used, especially in the pyramidal and granular cells (draft) of the hippocampal formation. At this time the label within these cells is very strong, see the D and I. (D and I) In the posterior cortical areas (e.g., somatosensorial cortex, s), the label in layer V is more apparent. The layer in VI is always devoid of label. At the hippocampal level, the pattern of ZnT3 mRNAs reveals that the label is weaker than in preceding days in the pyramidal cells (Py). Further, the differential label between CA2 (without ZnT3 expression), CA1, and CA3 reveals the specificity of the antisense probe. However, in granular cells of dentata gyrus (GrDG), the intensity of label is higher than in postnatal stages. Some nuclei in the thalamic area reveal ZnT3 expression, such as paraventricular (PV) and intermediodorsal (IMD) thalamic nuclei (D). (E and F) In adults, a steady system. Thus, cell markers within distinct neuroepithelia almost disappeared (Figs. 9A and 9D ). On the other hand, the number of labeled cells increased in the piriform cortex (Figs. 9M and 9N ), in the lateral amygdaloid nucleus, in the dentata gyrus (granular cells), and in the pyramidal cells of the CA3 and CA1 areas (Figs.  9D, 9I , 9J, and 9L). The high amounts of zinc in the hippocampus may explain why, at this time, the label was detected simultaneously in terminal fields of mossy fibers and inside the hippocampal cells (Figs. 9I and 9J ).
In cortical areas, a laminar cell pattern was seen, and a cell subpopulation in layer II-III and a few cells in layer V were observed. However, only the upper layers of cingular and retrosplenial cortical areas revealed a high number of labeled cells (Fig. 9B) . At this time, a few labeled cells in the corpus callosum were still detected (Figs. 9B and 9C) .
In the cerebellum, cell subpopulations of the fourth neuroepithelium and the locus coerelus nucleus revealed a marked increase in label compared with pre- vious stages. At this time, a few cells located in the EGL layer and in the white matter were already intensely labeled (Figs. 9G and 9H) .
On P12-P15, the distribution of CVZ cells was very similar to the adult ZnT3 expression pattern, supporting previous CVZ neuron studies (Howell and Frederickson, 1990; Slomianka et al, 1990) . Thus, the CVZ cells were located mainly in the cingular and piriform cortices, the hippocampal formation, and the amygdaloid nuclei (data not shown). A cortical laminar pattern was maintained as in preceding days (Figs. 10A-10C) . No label was detected in the remaining cerebral areas and the cerebellum, except in the cerebellar peduncle and in the intermediate and cellular reticular nuclei.
Analysis of Cell Subpopulations Labeled by a Double Procedure: Retrograde Selenium Method-Immunocytochemistry
Since the ZnT3 gene expression and the CVZ cells appeared in the white matter during development, we used a double procedure (the retrograde label method and the immunocytochemistry technique) to characterize the phenotype of these cells. The antibodies were tested against glial fibrilar acidic protein (GFAP), ␥-aminobutyric acid (GABA), different glutamatergic receptors such as GluR1, GluR2/3, mGluR2/3, and NMDA-R1 and PSA-NCAM (polysialyted isoform of neural cell adhesion molecule). During the first postnatal developmental stages (until P9), only GFAP-immunopositive retrograde labeled cells were detected (Figs. 10D and 10E), mainly located in the white matter and in different neuroepithelia (Figs. 10F and 10G ). From P12, CVZ cells immunopositive for NMDAR1 and GluR2/3 antibodies appeared, chiefly located in specific CVZ areas, such as the piriform cortex, the amygdala, the entorhinal cortex, and the hippocampus. Moreover, in the cortical layers, the double immunolabel was evident, thus neurons within layers II-III and layer V were GluR2/3 (Figs. 10A and 10B ) and NMDA-R1 immunopositive (Fig. 10C) .
In the cerebellum, no specific double label was determined at any stage of development. 
DISCUSSION
ZnT3 Expression and Distribution of CVZ Cells in Proliferative and Differentiating Areas
The expression of ZnT3 started early in development (E16) and lasted throughout embryonic life. It was mainly detected in proliferative and differentiating areas. During the first week of postnatal development, the label in these areas increased slightly but started to drop at later postnatal stages. Thus, from P0 to P12, ZnT3 mRNAs were found in proliferative cerebral zones (Kaufman, 1999) , such as ependymal cells of the lateral ventricle and cells of the subventricular zone. Further, at these stages label appeared in the EGL, which has a proliferation of granular cells during the first stages of development. Thereafter, cells commenced a program of radial migration into the anlage. During this journey the intensity of ZnT3 labeling in the EGL layer decreased steadily, and the label started to appear in the IGL. In adults, the label in cerebellar layers was at first completely absent. This datum is not consistent with results reported by Wang et al. (2002) in adult mice, which revealed immunoreactive ZnT3 at the axonal terminals in the cerebellar layers. Together with this labeling in proliferative areas in early postnatal development, the transcripts were also observed in differentiating areas such as the neocortex, the posterior pons nucleus of the cerebellum, and the amygdala (Kaufman, 1999) . This suggests that the ZnT3 protein may interact in the molecular processes that occur during cell proliferation and cell differentiation. So, ZnT3 would be implicated in the uptake of vesicular zinc required for the early binding zinc proteins, such as different metalloenzymes and zinc finger transcription factors (MacDonald, 2000; Beyersmann and Haase, 2001 ). This hypothesis is reinforced if we take into account that the ZnT3 expression in the adult is evident in areas with proliferation and differentiation activity (dentata gyrus, accessory olfactory bulb, olfactory nerve layer, and posterior pons cerebellum nucleus) (Kaufman, 1999) .
Comparing the expression pattern of ZnT3 with the distribution of CVZ cells at postnatal developmental stages, inexact correlation was determined, particularly between P0 and P9. Thus, at these stages, a high number of CVZ cells were found in the choroidal plexus, in the neuroepithelia of the hypothalamic arcuate nucleus, and in the white matter of the cerebellum, areas devoid of hybridization signals for the ZnT3 gene. These data support that other protein zinc transporters, besides ZnT3, may be involved in both uptake and release, in order to maintain intracellular zinc homeostasis and to release zinc across the brain barrier system. In this way, the brain peptide/histidine transporter (PHT1) has been implicated in zinc transport into the brain across the brain barrier system. The gene for this protein (PHT1) is expressed in the choroid plexus, however, it is not clear whether histidine-bound forms cross the plasma membranes of the choroidal epithelial cells and brain capillary endothelial cells (Yamashita et al., 1997; Takeda, 2001 ). Thus, Gunshin et al. (1997) suggested that PHT1 might transfer zinc to DMT1, a divalent metal transporter that is expressed in brain capillary endothelial cells and choroid epithelial cells. Besides, other zinc transporters (ZIP and CDF family) may be involved in zinc transport across the brain barrier system (Grotz et al., 1998; Gaither and Eide, 2000) .
Further, Valente et al. (2002) report that the pool of vesicular zinc is clearly higher during development than in the adult. These findings together with the present results on the CVZ pattern during development reinforce the hypothesis of several separate CVZ pools of zinc, mainly at the early postnatal stages, and that consequently more proteins or protein complexes, in addition to ZnT3, could be involved in zinc vesicular transport. Given that ZnT4 is highly expressed in brain (Liuzzi et al., 2001 ), it will be interesting to investigate the expression pattern of ZnT4 in the different brain areas relative to that of ZnT3 during development. This will allow us to determine whether ZnT3, a synaptic zinc transporter, and ZnT4, an endosomal zinc transporter, interact in the delivery of zinc to vesicles (cytoplasmatic and synaptic). Our findings agree with those of Palmiter et al. (1996b) , who report that an overexpression of ZnT3 alone does not confer zinc resistance. Therefore, they suggest that ZnT3 may be one component of a complex process required for zinc uptake into synaptic vesicles. A functional redundancy and possible interaction of the zinc transport proteins would therefore seem to be in the delivery of zinc into synaptic vesicles. Hence, it will be interesting to analyze whether these interactions change as development proceeds and whether they follow a correlation with different CVZ pools.
Differential Distribution of CVZ Cells in Developmental Stages to Adulthood
The distribution of CVZ cells showed changes in different brain areas, continuing throughout development until the adult stage. To gain insight into the nature of these cells, we applied immunolabeling techniques. Thus, during the first stages of postnatal devel- opment, CVZ cell subpopulations, mainly located in the white matter and the neuroepithelia, were revealed as GFAP immunopositive. But at these stages a high number of CVZ cells were not immunopositive for any of the antibodies tested. Consequently, further studies must be performed to identify specific protein markers for these cell subtypes. This would be the first step toward providing new insights into CVZ cell functions. As development proceeds, the number of GFAP-positive CVZ cells decreased and, from P12 onward, no glial immunopositive cells were visualized. During this period, the presence of CVZ cells immunolabeled for glutamatergic receptors, such as NMDA-R1 and GluR2/3, increased noticeably until adulthood. Therefore, these results supported the view that, at least in the later development and in the adult stage, most of the labeled CVZ cells are subtypes of glutamatergic neurons (Haug 1967; Pérez-Clausell and Danscher, 1985; Beaulieu et al., 1992; Frederickson et al., 2000) . Although we found no CVZ cells immunopositive for GABA antibody, we should consider the work done by Wang et al. (2002) in which they detect chelatable zinc in the GABAergic system in the mouse cerebellar cortex.
All these findings suggest that different CVZ cell subpopulations exist throughout development. They also report that vesicular zinc levels are important at early stages of development, and that they are required for early glial processes.
Expression Pattern of ZnT3 Compared with the Distribution Pattern of CVZ Cells in Adult Organism
The adult CVZ circuits (terminal fields and neurons) have been extensively described by different methods, all of which find a total correlation (Danscher, 1984; Pérez-Clausell and Danscher, 1985; Frederickson and Danscher, 1992; Wenzel et al., 1997; Jo et al., 2000) . In the present work, the expression pattern of ZnT3 determined in the adult organism by nonradioactive in situ hybridization coincides with the results obtained by Palmiter et al. (1996b) using radioactive riboprobes. However, we determined that, in the adult, the expression of ZnT3 in neocortical areas displayed few differences, one of these being the number of the cells detected in the cortical layers. Nevertheless, this pattern coincides with the distribution of glutamatergic neurons that contain zinc synaptic vesicles or gluzinergic neurons (Frederickson, 1989; Frederickson and Moncrieff, 1994; Frederickson et al., 2000) . Along these lines, Slomianka et al. (1990) and Casanovas-Aguilar et al. (1995) have pointed out that, in layer V, larger pyramidal neurons are virtually always cells without zinc synaptic vesicles. While further studies are needed in order to clarify these differences, at least at the cortical level, the cell patterns presented here reinforced the relation of ZnT3 protein with zinc vesicular uptake. Our findings also support the results obtained by Cole et al. (1999) with ZnT3 ϩ/Ϫ mice, detecting less zinc in synaptic vesicles, and with ZnT3
Ϫ/Ϫ mice, revealing no chelatable zinc within synaptic vesicles. These results were found in brain, but removal of ZnT3 from other tissues did not affect the chelatable vesicular zinc found. This occurs in the secretory granules of pancreatic ␤-islet cells (Toroptsev et al., 1974) , salivary gland granular convulated tubule cells (Frederickson et al., 1987) , germ cells of the testis (Danscher and Zimmer, 1978; Andrews et al., 1995) , and cuboidal cells of the choroid plexus (Frederickson, 1989) . These findings, within different tissues, appear to us to reinforce our hypothesis about the existence of different CVZ pools as occurs in development, since they suggest that an interaction between different protein complexes must be required in zinc vesicular transport.
Conclusions
Further questions about the implication of ZnT3 protein in zinc vesicular transport arise when the expression pattern of ZnT3 is compared with the distribution of CVZ cells. The lack of correlation between the two patterns during the first postnatal developmental stages suggests the presence of different transporter proteins in the zinc uptake into vesicles. To locate differential phenotypes of CVZ cells during development, we should point out that various chelatable vesicular pools of zinc could coexist throughout development. Further approaches are now needed to clarify whether zinc has specific functions in brain development and which zinc transporter proteins are involved in the zinc homeostatic control.
In addition, the high levels of ZnT3 expression detected in different proliferating and differentiating fields support the hypothesis that ZnT3 protein probably takes part in the uptake of vesicular zinc involved in the early binding zinc proteins (transcription factors and metalloproteins). These are highly expressed during these cellular events. 
EXPERIMENTAL METHODS
Animals
NMRI (Iffa Credo, Lyon, France) mouse embryos from E14 to E18, postnatal animals from P0 to P18, and adults were used for in situ hybridization, retrograde tracer, and immunohistochemistry studies. The day on which a vaginal plug was detected was considered embryonic day 0 (E0). E1 began 24 h later. The day of birth (and the first 24 h after birth) was designated P0. The day beginning 24 h after birth was P1.
Fetal Animals
In all cases, time-pregnant females were deeply anesthetized by intraperitoneal injection of ketamine (100 mg/kg) and Xilacine (10 mg/kg). The fetal animals were removed from the mother. Dissected brains were perfused and stored according to the method used.
Postnatal Animals
Postnatal animals younger than P5 were anesthetized by hypothermia and the others were deeply anesthetized by intraperitoneal injection of ketamine (100 mg/ kg) and Xilacine (10 mg/kg). Afterward, all of them were perfused and the brains were quickly dissected and processed according to the method applied.
Principles of Laboratory Animal Care
The animals were kept under controlled conditions of temperature, humidity, and light and were treated according to European Community Council Directive 86/609/EEC and the procedure registered at the Department d'Agricultura, Ramaderia i Pesca of the Generalitat de Catalunya. Every effort was made to minimize animal suffering. Pregnant females and postnatal and adult animals were deep-anesthetized before perfusion. Postnatal animals were removed from their mothers just before beginning the perfusion.
In Situ Hybridization
Fetal animals (E14 -E18), postnatal animals (P0 -P18), and adult mice (two animals each) were perfused with 4% paraformaldehyde in 0.1 M phosphate buffer (PFA). The brains were removed and immediately immersed in the same fixative solution for 24 h at 4°C. The brains were then cryoprotected with 30% sucrose in PFA, frozen on dry ice, and sectioned at 30 -50 m in a cryostat (coronal sections). Finally, they were stored in a cryoprotectant solution (30% glycerol, 30% ethylenglycol, and 40% of 0.1 M phosphate buffer, pH 7.4).
Antisense riboprobes were labeled with digoxigenind-UTP (Boehringer-Mannheim) by in vitro transcription of mouse cDNA encoding ZnT3 (Palmiter et al., 1996b) .
In situ hybridization was performed on free-floating tissue sections. Sections were rinsed in phosphate-buffered saline (PBS), treated with H 2 O 2 with 0.1-0.2 N HCl (according to age), and acetylated in 0.1 M triethanolamine with 0.25% acetic anhydride. After this treatment, sections were prehybridized for 3 h at 60°C in a solution containing 50% formamide, 5ϫ sodium saline citrate (SSC), 1% sodium dodecyl sulfate (SDS), 250 g/ml sheared salmon sperm DNA, and 250 g/ml yeast tRNA. Subsequently, in the same prehybridization buffer, antisense or sense ZnT3 digoxigenin-d-UTP-labeled riboprobes (0.85 g/ml) were added. ISH was performed at 60°C overnight. After ISH, sections were washed in solution I (50% formamide, 5ϫ SSC, and 1% SDS) for 1 h at 60°C and washed at room temperature (RT) in solution II (0.5 M NaCl, 10 mM Tris-HCl, pH 7.5, and 0.1% Tween-20). The sections were then successively incubated in solution II (with 100 g/ml RNase A) and in solution III (50% formamide and 2ϫ SSC), at 37 and 55°C, respectively. After the stringent washes, sections were rinsed in TBST (135 mM NaCl, 3 mM KCl, 0.1% Tween-20, 2 mM levamisole, and 25 mM Tris-HCl, pH 7.5) and incubated for 2 h at RT in a blocking solution containing 10% normal goat serum (NGS) in TBST. After rinsing, sections were incubated overnight at 4°C with an alkaline phosphatase-labeled antidigoxigenin antibody (1:2000; Boehringer-Mannheim) in 5% NGS in TBST. To view alkaline phosphatase activity, sections were incubated with nitroblue tetrazolium salt and 5-bromo-4-chloro-3-indolyl-phosphate toluidinium salt (BCIP) diluted in a NTMT solution (100 mM NaCl, 50 mM MgCl 2 , 0.1% Tween-20, 2 mM levamisole, and 100 mM Tris-HCl, pH 9.5). Alkaline phosphatase activity was then stopped in PBS and the sections were mounted on gelatinized slides. Control of hybridization with sense strandlabeled riboprobes showed no hybridization signal (Fig. 4J) .
Detection of CVZ Cells by the Retrograde Transport of Zinc-Selenium Precipitates
CVZ cells are defined as cells that sequester ionic zinc (Zn 2ϩ ) inside the synaptic vesicles. This pool could be detected histochemically by the precipitation of zinc ions with sulphide or selenium salts (Danscher sele-nium method, i.e., a modification of the Timm method (Danscher, 1984) ). In order to study the pattern of CVZ cells during development, 24 mice in total (three per postnatal age) were processed, according to the Danscher selenium method (Danscher, 1984; Danscher et al., 1985) . Under hypothermia anesthesia, mice were injected intraperitoneally with Na 2 SeO 3 at a final dose of 6.5 mg/kg for ՅP9 and 8.0 mg/kg for ϾP9. After 15-24 h of survival (depending on the postnatal stage: for animals younger than P9 survival time was shorter), the animals were deeply anesthetized by intraperitoneal injection of ketamine (100 mg/kg) and Xilacine (10 mg/kg) or by hypothermia for younger animals. After that, the animals were transcardially perfused with 0.9% NaCl for 10 -15 min. The brain was quickly removed and frozen in carbonic ice. Four series of cryostat sections 30-m thick were cut, air dried, and stored at Ϫ20°C before use.
To detect endogenous zinc precipitates, transported in a retrograde way, three series of each set of four were processed according to Danscher (1981 Danscher ( , 1982 . Briefly, sections were immersed in a solution containing gum arabic, citrate buffer, hydroquinone, and silver lactate (silver amplification mix). They were developed in the dark at 26°C for 65 min. Negative control animals at ages between P0 and P12, receiving no selenite injection but with the sections silver enhanced as described above, were used.
Double Danscher-Immunocytochemistry Procedure
P0 -P18 postnatal and adult mice (two animals each) were injected intraperitoneally with 1.5% Na 2 SeO 3 at a final dose of 15 mg/kg, as described above. After 15-24 h survival they were perfused with PFA. The brains were removed immediately and immersed in the same fixative solution for 4 h at 4°C. After postfixation, the brains were cryoprotected with 30% sucrose in PFA, frozen on dry ice, sectioned at 30 m in a cryostat (coronal sections), and stored in a cryoprotectant solution (as described above). Free-floating sections were rinsed in PBS to eliminate the cryoprotectant solution and then immersed in a silver amplification mix (described above). They were developed in the dark at RT for 50 -65 min. After several rinses in PBS at 4°C, sections were treated with 0.3% H 2 O 2 and 10% methanol in PBS for 15 min to block endogenous peroxidase. After rinsing in PBS, the sections were treated with 10% NGS, 0.2 M glycine, and 0.2% lysine in PBST (0.2% Triton X-100 in PBS) for 2 h to block nonspecific staining. After rinsing, sections were incubated overnight at 4°C in PBST, containing 5% NGS with one of the following primary antibodies: rabbit anti-GluR2/3 (1:1000), rabbit anti-NMDAR1 (1:1000), rabbit anti-GABA (1:1000), rabbit anti-GFAP (1:2000), rabbit anti PSA-NCAM (1:7500), and rabbit anti-GluR1 (1:750). Thereafter, sections were sequentially incubated with biotinylated goat anti-rabbit antibodies (1:200) and with avidin-biotin-peroxidase complex (1:200). Peroxidase was developed with 0.05% diaminobenzidine in 0.1 M PB and 0.01% H 2 O 2 , and immunoreacted sections were mounted onto gelatinized slides.
Analysis of the Anatomical Brain Areas
Different brain areas were defined following Schambra et al. (1992) , Altman and Bayer (1995) , and Kaufman (1999) for developing animals and Paxinos and Watson (1998) and Franklin and Paxinos (1997) for adult animals.
